Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04839302 · ClinicalTrials.gov registry record
Detection and Delineation of Necrotizing Fasciitis Via a Vascular Perfusion Fluorophore
A clinical trial of Necrotising Fasciitis, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- 18
- Enrollment target
- 1
- Study location
NCT04839302 is a study of Necrotising Fasciitis that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 18 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04839302, a study of Necrotising Fasciitis, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this work is to determine if fluorescence signal intensity changes from a vascular perfusion fluorophore (indocyanine green) can be associated with the presence of necrotizing fasciitis. Hypothesis - Tissue regions affected with necrotizing fasciitis will demonstrate reduced fluorescence intensity compared to an unaffected region without clinical evidence of necrotizing fasciitis.
Conditions Studied
Interventions
- DRUG Indocyanine green solution
Study Locations (1)
New Hampshire
- Dartmouth-Hitchock - Lebanon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2021-04-05 |
| Est. Completion | 2024-12-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04839302
The ClinicalTrials.gov registry entry for NCT04839302 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Necrotising Fasciitis appearing as the primary indexed condition, and to 1 intervention - of which Indocyanine green solution is the first listed.
NCT04839302 reports 1 study location spanning 1 distinct geographic area - top geographies include New Hampshire.
Frequently Asked Questions
What is clinical trial NCT04839302 about?
NCT04839302 is a clinical study titled "Detection and Delineation of Necrotizing Fasciitis Via a Vascular Perfusion Fluorophore". The primary objective of this work is to determine if fluorescence signal intensity changes from a vascular perfusion fluorophore (indocyanine green) can be associated with the presence of necrotizing fasciitis. Hypothesis - Tissue regions affected with necrotizing fasciitis will demonstrate reduce...
What is the current status of trial NCT04839302?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2021-04-05. Estimated completion is 2024-12-04.
What conditions does trial NCT04839302 study?
This clinical trial studies the following conditions: Necrotising Fasciitis.
What interventions are being tested in trial NCT04839302?
The interventions under investigation include: Indocyanine green solution (DRUG).
Who is sponsoring clinical trial NCT04839302?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04839302 being conducted?
This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.